Shockwave Therapy for Calcific Tendinitis of the Shoulder

What is established

Extracorporeal shockwave therapy, ESWT, delivers focused or radial pressure waves through the skin to a target tissue. As a procedure it is well characterized and has been used in orthopedics and sports medicine for decades, originating from lithotripsy technology adapted for musculoskeletal use. The device, the energy delivery, and the basic safety profile are not in question.

What is specific to this article is one indication: calcific tendinitis of the rotator cuff, a condition where calcium deposits form within the tendon, most often the supraspinatus, and cause pain that can become chronic when the deposit does not resorb on its own. This is a distinct diagnosis from generic rotator cuff tendinopathy without calcification, and the two should not be treated as the same condition when reviewing evidence.

What the evidence for this specific use actually shows

The most complete synthesis is a systematic review by Bannuru and colleagues covering 28 randomized controlled trials of high-energy ESWT for chronic calcific tendinitis of the shoulder. Compared with placebo, high-energy ESWT produced clinically meaningful improvements in pain, shoulder function, and quality of life, and it increased the rate of complete or partial resorption of the calcific deposit on imaging.[1]

The review also found that the benefit was not uniform across all calcific deposits. Effects were strongest for deposits classified as type II or III, meaning denser, sharply demarcated calcifications, and weaker or unclear for diffuse, poorly defined, or fluffy calcifications that are harder for the shockwave to target and break down. Energy dose mattered too: high-energy protocols outperformed low-energy ones, though trials varied in how they defined and delivered that energy.[1]

The trap: calcification type is not optional detail

A shoulder that hurts is not automatically a shoulder that will respond to ESWT. The evidence base for benefit sits specifically inside calcific tendinitis, confirmed by imaging, with attention to how the deposit looks. Treating shoulder pain in general as if the calcific tendinitis trial evidence applies is a misuse of that evidence.[1]

What remains uncertain

The reviewers were explicit that the number of trials directly comparable to one another was small once energy dose, calcification classification, and outcome measures were accounted for. Heterogeneity in these factors means the pooled effect size should be read as a reasonable estimate rather than a precise number. Longer-term outcomes beyond the trial follow-up windows, and how ESWT compares directly with other established options such as ultrasound-guided needling and lavage, are not settled by this body of evidence.[1]

There is also a clear negative finding worth stating plainly: this evidence does not support ESWT for noncalcific rotator cuff tendinitis. That negative result is part of the same review and should not be dropped when the therapy is discussed.[1]

What this means for you

Shoulder pain is not treated as a single problem with a single device answer. Imaging comes first, to confirm whether a calcific deposit is present at all and, if so, whether it is the dense, well-defined type the evidence supports or a diffuse type where benefit is far less certain. That diagnostic step decides whether ESWT is even a relevant option, before any discussion of sessions or energy settings.

Where calcific tendinitis of the appropriate type is confirmed, the physician weighs ESWT against the other established options for this condition, including watchful waiting, needling and lavage, and standard rehabilitation, based on the individual patient's deposit characteristics, symptom duration, and prior treatment. AION does not offer a fixed protocol or a guaranteed outcome, and does not use this evidence to justify shockwave therapy for shoulder pain generally.[1]